This inventor holds 3 USPTO granted patents. Top assignee: Pfizer Corporation. Active years: 1998-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-2003
Title: Susan J Truesdell: Innovator in Microbial Biotransformation
Introduction
Susan J Truesdell is a prominent inventor based in Warwick, RI (US). She has made significant contributions to the field of microbial biotransformation, holding a total of 3 patents. Her work focuses on the innovative use of microorganisms to enhance pharmaceutical processes.
Latest Patents
Among her latest patents is the invention titled "Stereoselective microbial reduction of a racemic tetralone." This patent highlights her expertise in utilizing specific microorganisms from the Monosporium and Thamostylum genera to diastereoselectively O-demethylate pharmaceutical intermediates. This process is crucial for producing compounds that are essential in the pharmaceutical industry.
Career Highlights
Susan is currently employed at Pfizer Corporation, where she continues to push the boundaries of innovation in her field. Her work at Pfizer has allowed her to collaborate with leading experts and contribute to groundbreaking research that impacts the development of new pharmaceuticals.
Collaborations
Throughout her career, Susan has worked alongside notable colleagues, including Brook K Morse and John Wing Wong. These collaborations have fostered a dynamic environment for innovation and have led to significant advancements in microbial biotransformation.
Conclusion
Susan J Truesdell is a trailblazer in the field of microbial biotransformation, with a strong portfolio of patents and a commitment to advancing pharmaceutical science. Her contributions continue to shape the future of drug development and innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile